Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 33075061.
- Also identified by DOI 10.1371/journal.pone.0240358 and PMC identifier 7572073.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[NCT03677921]; www.clinicaltrials.gov [KCT0002726]; https://cris.nih.go.kr.
Medical subject headings
- Germanium
- Immunoglobulin G
- Killer Cells, Natural
- Tumor Necrosis Factor-alpha